As expected, sera from patients with HCC displayed a significantly stronger response to the recombinant ZCCHC13 protein than sera from healthy controls, verifying the increased levels of the ZCCHC13 protein in tissues from patients HCC. This evidence concerns the gene ZCCHC13 and hepatocellular carcinoma.